Advisory Services Network’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,200
Closed -$2.44K 1917
2023
Q4
$2.44K Buy
+2,200
New +$3.27K ﹤0.01% 3348
2023
Q2
Sell
-2,200
Closed -$7.41K 1918
2023
Q1
$7.41K Hold
2,200
﹤0.01% 2996
2022
Q4
$3.41K Buy
+2,200
New +$3.26K ﹤0.01% 3258
2021
Q3
Sell
-7,380
Closed -$56K 1794
2021
Q2
$56K Buy
+7,380
New +$62.2K ﹤0.01% 1926
2021
Q1
Sell
-7,380
Closed -$59K 1633
2020
Q4
$59K Sell
7,380
-300
-4% -$2.51K ﹤0.01% 1574
2020
Q3
$61K Buy
+7,680
New +$69.3K ﹤0.01% 1488
2020
Q2
Sell
-5,680
Closed -$44K 1369
2020
Q1
$44K Buy
5,680
+2,590
+84% +$13.1K ﹤0.01% 1449
2019
Q4
$12K Sell
3,090
-410
-12% -$1.79K ﹤0.01% 2259
2019
Q3
$23K Hold
3,500
﹤0.01% 1739
2019
Q2
$23K Buy
3,500
+2,000
+133% +$13.7K ﹤0.01% 1737
2019
Q1
$11K Buy
+1,500
New +$11.7K ﹤0.01% 1806
2016
Q2
Sell
-6,460
Closed -$25K 1853
2016
Q1
$25K Hold
6,460
0.01% 861
2015
Q4
$36K Hold
6,460
0.01% 661
2015
Q3
$41K Hold
6,460
0.01% 574
2015
Q2
$42K Sell
6,460
-200
-3% -$1.36K 0.01% 552
2015
Q1
$49K Buy
+6,660
New +$68.5K 0.01% 497

Other funds holding CTSO

Advisory Services Network's CTSO Position: Q1 2024 in Review

Advisory Services Network sold out of Cytosorbents Corp (CTSO) in Q1 2024, closing a stake of 2,200 shares — an estimated $2.44K sold.

Advisory Services Network first reported a position in CTSO in Q1 2015 and held it in 16 quarters. The position peaked at $61K in Q3 2020. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2024.

  • Advisory Services Network reported no remaining Cytosorbents Corp position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 2,200 Cytosorbents Corp shares in Q1 2024, an estimated $2.44K.
  • Advisory Services Network first reported a position in Cytosorbents Corp in Q1 2015 and held it in 16 quarters.
  • Advisory Services Network's Cytosorbents Corp position peaked at $61K in Q3 2020.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.